Robertson Stephens Wealth Management’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.55M Buy
31,341
+3,294
+12% +$167K 0.04% 246
2026
Q1
$1.5M Buy
28,047
+1,337
+5% +$78.5K 0.04% 242
2025
Q4
$1.66M Buy
26,710
+2,425
+10% +$150K 0.04% 236
2025
Q3
$1.46M Buy
24,285
+2,535
+12% +$155K 0.04% 212
2025
Q2
$1.36M Buy
21,750
+3,046
+16% +$183K 0.04% 229
2025
Q1
$1.13M Sell
18,704
-1,142
-6% -$70.9K 0.04% 256
2024
Q4
$1.16M Buy
19,846
+1,284
+7% +$76.3K 0.04% 246
2024
Q3
$1.1M Sell
18,562
-51
-0.3% -$2.91K 0.04% 264
2024
Q2
$1.04M Buy
18,613
+2,980
+19% +$167K 0.05% 222
2024
Q1
$916K Buy
15,633
+278
+2% +$15.7K 0.05% 245
2023
Q4
$829K Sell
15,355
-251
-2% -$12.3K 0.05% 243
2023
Q3
$759K Sell
15,606
-2,480
-14% -$132K 0.05% 241
2023
Q2
$1.02M Sell
18,086
-4,361
-19% -$240K 0.07% 192
2023
Q1
$1.21M Sell
22,447
-1,502
-6% -$80K 0.09% 177
2022
Q4
$1.26M Buy
23,949
+18,009
+303% +$914K 0.12% 157
2022
Q3
$280K Buy
5,940
+78
+1% +$4.05K 0.03% 290
2022
Q2
$295K Sell
5,862
-22,477
-79% -$1.23M 0.03% 294
2022
Q1
$1.73M Sell
28,339
-1,536
-5% -$91.6K 0.15% 128
2021
Q4
$1.97M Sell
29,875
-335
-1% -$21.4K 0.17% 114
2021
Q3
$1.9M Sell
30,210
-3,138
-9% -$200K 0.21% 74
2021
Q2
$2.01M Sell
33,348
-10,356
-24% -$599K 0.24% 71
2021
Q1
$2.41M Sell
43,704
-54
-0.1% -$3K 0.38% 51
2020
Q4
$2.39M Buy
43,758
+7,392
+20% +$386K 0.5% 46
2020
Q3
$1.82M Sell
36,366
-300
-0.8% -$14.5K 0.45% 47
2020
Q2
$1.62M Buy
36,666
+15,312
+72% +$654K 0.47% 50
2020
Q1
$802K Buy
21,354
+4,548
+27% +$191K 0.27% 77
2019
Q4
$740K Sell
16,806
-384
-2% -$16.1K 0.37% 47
2019
Q3
$708K Buy
17,190
+8,268
+93% +$338K 0.36% 56
2019
Q2
$358K Buy
+8,922
New +$338K 0.35% 49

Other funds holding IHI

Robertson Stephens Wealth Management's IHI Position: Q2 2026 in Review

Robertson Stephens Wealth Management increased its iShares US Medical Devices ETF (IHI) stake by 12% in Q2 2026, buying an estimated $167K and bringing the position to 31,341 shares worth $1.55M. The position accounts for 0.04% of the portfolio, ranked #246.

Robertson Stephens Wealth Management first reported a position in IHI in Q2 2019 and has held it in 29 quarters since. The position peaked at $2.41M in Q1 2021. 202 funds tracked by Wall St. Rank hold IHI as of Q2 2026.

  • Robertson Stephens Wealth Management held 31,341 shares of iShares US Medical Devices ETF worth $1.55M as of Q2 2026.
  • Robertson Stephens Wealth Management bought 3,294 iShares US Medical Devices ETF shares in Q2 2026, an estimated $167K.
  • iShares US Medical Devices ETF made up 0.04% of Robertson Stephens Wealth Management's portfolio in Q2 2026, its #246 holding.
  • Robertson Stephens Wealth Management first reported a position in iShares US Medical Devices ETF in Q2 2019 and has held it in 29 quarters since.
  • Robertson Stephens Wealth Management's iShares US Medical Devices ETF position peaked at $2.41M in Q1 2021.
  • 202 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.

Based on Robertson Stephens Wealth Management's 13F filing for Q2 2026, filed 29 Jul 2026.